May 31, 2021 Experience Esco Lifesciences $200 million Series A financing We are advising Esco Lifesciences on its Series A financing
May 17, 2021 Experience Charles River Laboratories acquisition of Vigene Biosciences We are advising Charles River on the acquisition
May 3, 2021 Experience Roivant Sciences combination with Montes Archimedes Acquisition We are advising Roivant Sciences on its combination with a SPAC
February 26, 2021 Experience Evernorth acquisition of MDLIVE We are advising MDLIVE on the transaction
February 24, 2021 Experience Reckitt Benckiser Group acquisition of Biofreeze We are advising RB on the acquisition
February 17, 2021 Experience Charles River Laboratories $875 million acquisition of Cognate We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
February 10, 2021 Experience Cornell Capital acquires trustaff and CardioSolution in combination with Stella We are advising Cornell Capital on the acquisition
December 21, 2020 Experience ImmunityBio merger with NantKwest Davis Polk is advising Goldman Sachs & Co. LLC and Lazard Frères & Co. LLC as financial advisers to ImmunityBio, Inc. in connection with its 100% stock-for-stock merger with…